688336 Sunshine Guojian Pharmaceutical
- 21.80
- +0.45+2.11%
Sunshine Guojian Pharmaceutical News
Sansheng Guojian: 2024 Semi-Annual Equity Distribution Implementation Notice
Sansheng Guojian: Announcement on the completion of the election of the Board of Directors and the Board of Supervisors and the appointment of senior management and securities affairs representatives
Legal Opinion of Guohao Law Firm (Shanghai) on the 2024 Third Extraordinary General Meeting of Shareholders of Sansheng Guojian Pharmaceutical (Shanghai) Co., Ltd.
Sansheng Guojian: Announcement of Resolutions of the First Meeting of the Fifth Board of Supervisors
Sansheng Guojian: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders
Kokuken Mitsubo: Announcement on the Election of Employee Representatives and Supervisors
Sansei Guojian: Announcement on holding the 2024 semi-annual results briefing
Sansheng Guojian: Announcement on receiving dividends from participating companies
Sansheng Guojian: 2024 Third Extraordinary General Meeting of Shareholders Meeting Information
Sansei Guojian: Investor Relations Activity Record List (August 23-26, 2024)
Sunshine Guojian Pharmaceutical: Notice on convening the third extraordinary shareholder meeting in 2024.
Sunshine Guojian Pharmaceutical: Announcement of Resolutions of the Twentieth Meeting of the Fourth Supervisory Board.
Sunshine Guojian Pharmaceutical: Announcement Regarding the Plan for Profit Distribution in Mid-2024
Sunshine Guojian Pharmaceutical: Special report on the use and deposit of funds raised in the first half of 2024 for the company.
Sunshine Guojian Pharmaceutical: Semi-annual evaluation report on the 'Quality Improvement and Efficiency Enhancement for Return' action plan for the company's 2024 fiscal year.
Sunshine Guojian Pharmaceutical: Half-year report for the year 2024.
Sunshine Guojian Pharmaceutical: Summary of Half-Year Report in 2024.
Sunshine Guojian Pharmaceutical: Announcement regarding the continuing use of temporarily idle funds raised for cash management.
China Merchants Securities Co., Ltd.'s verification opinion on Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.'s continued use of a portion of temporarily idle raised funds for cash management.
Sunshine Guojian Pharmaceutical: Statement and Commitment of the Nominee Independent Director (Zhang Wei)
Analysis
Price Target
No Data
No Data